Genenta Science (GNTA)

• Market cap: $31.2M
• 1 day: -0.75%
• 5 days: -2.21%
• 1 month: -11.33%
• 3 months: -58.82%
• 6 months: -64.81%
• Year to date: -5.67%
• 1 year: -68.26%
• 5 years: -87.91%
• 10 years: -87.91%
• Sector: Healthcare
• Industry: Biotechnology

About: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Employees: 13